Key regions: United States, Europe, Brazil, Japan, United Kingdom
Bronchodilator drugs are a class of medication used to treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. In Gabon, the market for bronchodilator drugs is developing at a steady pace.
Customer preferences: Gabon has a high prevalence of respiratory diseases, which has led to an increase in the demand for bronchodilator drugs. The majority of the population in Gabon relies on public healthcare services, which has resulted in a preference for affordable medications. However, there is also a growing demand for high-quality medication among the urban population.
Trends in the market: The bronchodilator drugs market in Gabon is witnessing a trend towards the use of combination drugs. Combination drugs are a combination of two or more medications in a single inhaler. This trend is driven by the convenience of using a single inhaler for multiple medications. Additionally, combination drugs have been shown to be more effective in treating respiratory diseases than single drugs.Another trend in the market is the increasing use of generic bronchodilator drugs. The high cost of branded drugs has led to a preference for generic drugs among the population. This trend is expected to continue in the future as the government is promoting the use of generic drugs to reduce healthcare costs.
Local special circumstances: Gabon has a small population and a relatively small healthcare market. The country is heavily dependent on imports for medication, which has resulted in a high cost of medication. The government has implemented policies to reduce the cost of medication, including the promotion of generic drugs and price controls on medication.
Underlying macroeconomic factors: Gabon is a middle-income country with a growing economy. The government has implemented policies to diversify the economy and reduce dependence on oil exports. The healthcare sector is a priority area for the government, and there have been investments in healthcare infrastructure and services. However, the healthcare sector in Gabon still faces challenges, including a shortage of healthcare professionals and inadequate healthcare facilities in rural areas.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
